Medika Natura: Pioneering the Future of Obesity Management in Malaysia
We are pleased to announce a breakthrough achievement by Medika Natura in the field of obesity and metabolic syndrome research.
Our team has successfully completed the FIRST human clinical trial in Malaysia on SKF7®️ (a patented standardized extract of Labisia pumila), revealing its potential as a novel therapeutic treatment for obesity.
Published in the respected Diabetes, Obesity, and Metabolism Journal – a prestigious, peer-reviewed medical publication released monthly – our clinical efforts have undergone meticulous peer review, further enhancing the legitimacy of our discoveries. Boasting an impressive ranking of 31/145 in the Endocrinology & Metabolism (Science) category, this journal underscores the quality, rigor, and significance of our research.
SKF7®️ is derived from Labisia pumila, a native Malaysian medicinal plant widely recognized as Kacip Fatimah. Our study highlights its promising ability to effectively reduce waist circumference and waist-to-height ratio in individuals with obesity, correlated with a reduction in visceral fat among this population. The importance of reducing visceral fat extends beyond aesthetic concerns, as excess visceral fat has been associated with heightened risks of various metabolic diseases, including cardiovascular conditions and diabetes.
We take pride that SKF7®️ has also been granted regulatory clearance by the United States Food and Drug Administration (FDA) as a New Dietary Ingredient. In the same year, 2022, the European Food Safety Authority (EFSA) granted SKF7®️ the status of a Novel Food. These significant accomplishments underscore the safety of SKF7®️ and pave the way for international market expansion. Our dedication was further affirmed with the grant of a patent in 2022, solidifying our position as leaders in obesity research and innovation.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 44b Jalan Bola Tampar 13/14, Section 13,malaysia
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- orchidlife.com.my
- Keywords
- healthcare, natural, clinical, USFDA, EFSA, botanical.
- HQ
- Shah Alam, Selangor
Medika Natura Sdn Bhd Questions
Medika Natura Sdn Bhd's website is orchidlife.com.my
Medika Natura Sdn Bhd's LinkedIn profile is https://my.linkedin.com/company/medikanatura
Medika Natura Sdn Bhd has
7 employees.
View email and phone details for 7
employees at Medika Natura Sdn Bhd.
Medika Natura Sdn Bhd's industry is
Pharmaceutical Manufacturing
Medika Natura Sdn Bhd's top competitors are
Xorix Sdn. Bhd.,
Stadpharm Sdn Bhd,
Novugen,
Jardin Pharma Berhad,
Xepa-Soul Pattinson (Malaysia) Sdn Bhd,
Pharmaniaga Berhad,
Aba Pharma Sdn Bhd,
Duopharma Biotech Berhad,
Mayflax,
Teraju Pharma Group.
Medika Natura Sdn Bhd's categories are Pharmaceutical Manufacturing
Medika Natura Sdn Bhd's founding year is 2006
